Tritiation of several antihypertensive agents at high specific activity

Applied Radiation and Isotopes

Volumn 66, Issue 10, 2008, Pages 1392-1395

  Andrews, Joseph R ^a   Egan, Judith A ^a   Filer, Crist N ^a  

^a PERKINELMER INC   (United States)

Author keywords

Hypertension; Lacidipine; Telmisartan; Tritium NMR

Indexed keywords

HYPERTENSION; LACIDIPINE; SPECIFIC ACTIVITY; TELMISARTAN; TRITIATION; TRITIUM NMR;

TRITIUM;

ANTIHYPERTENSIVE AGENT; LACIDIPINE; TELMISARTAN; TRITIUM;

ANALYTIC METHOD; ARTICLE; ISOTOPE LABELING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIOACTIVITY;

ANTIHYPERTENSIVE AGENTS; ISOTOPE LABELING; RADIOISOTOPES; TRITIUM;

EID: 48849088545     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2008.03.001     Document Type: Article

References (15)

1. Battershill A.J., and Scott L.J. Telmisartan: a review of its use in the management of hypertension. Drugs 66 (2006) 51-83
2. 3H] DUP-753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype. Biochem. Biophys. Res. Commun. 172 (1990) 1195-1202
3. 3H] lisinopril. Synth. Commun. 34 (2004) 2473-2477
4. Egan J.A., Laseter A.G., and Filer C.N. Tritium labelling and characterization of the antimalarial drug (±)-chloroquine by several methods. Appl. Radiat. Isot. 57 (2002) 343-345
5. Graziani F., Ratti E., and Van Amsterdam F.T.M. Interaction of lacidipine with its receptor binding site supports a slow onset and long duration of action. J. Cardiovasc. Pharmacol. 27 (1996) 290-296
6. Grossi P., Pellegatti M., Vigelli G., Ayrton J., Duncan B.A., Evans G.L., and Maltas J. Lacidipine metabolism in rat and dog. Identification and synthesis of main metabolites. Xenobiotica 22 (1992) 899-916
7. Imai J. Clinical hypertension review. Ther. Res. 27 (2006) 1413-1472
8. Le M.T., Pugsley M.K., Vauquelin G., and Van Liefde I. Molecular characterization of the interactions between olmesartan and telmistartan and the human angiotensin II AT1 receptor. Br. J. Pharmacol. 151 (2007) 952-962
9. Meldolesi J., and Pozzan T. Pathways of calcium influx at the plasma membrane: voltage-, receptor-, and second messenger-operated channels. Exp. Cell Res. 171 (1987) 271-283
10. Oparil S., Silfani T.N., and Walker J.F. Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals. J. Hypertens. 18 (2005) 287-294
11. 3H] L-158,809. Bioorg. Med. Chem. Lett. 3 (1993) 557-560
12. Salomone S., and Godfraind T. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines isradipine and lacidipine, with calcium channels in smooth muscle. Br. J. Pharmacol. 109 (1993) 100-106
13. 5 vascular smooth muscle cells. Eur. J. Pharmacol. 244 (1993) 139-144
14. Su Y.R., and Menon A.G. Epithelial sodium channels and hypertension. Drug Metab. Dispos. 29 (2001) 553-556
15. Tanabe T., Takeshima H., Mikami A., Flockerzi V., Takahashi H., Kangawa K., Kojima M., Matsuo H., Hirose T., and Numa S. Primary structure of the receptor of calcium channel blockers from skeletal muscle. Nature 328 (1987) 313-318